Fourth Amendment to Patent License Agreement
Exhibit 10.23
Fourth Amendment to Patent License Agreement
This Fourth Amendment (“Fourth Amendment”) to the License Agreement (License ID: 80471) (“License Agreement”) is effective July ___, 2023 (the “Fourth Amendment Effective Date”) by and between the University of Central Florida Research Foundation, Inc., having an address and place of business at 00000 Xxxxxxxx Xxxxxxx, Xxxxx 000, Xxxxxxx, Xxxxxxx, 00000 (the “LICENSOR”), and Hesperos, Inc., a Delaware corporation authorized to conduct business in Florida as a foreign corporation, having an office and place of business at 00000 Xxxxxxxx Xxxxxxx, Xxxxx 000, Xxxxxxx, Xxxxxxx 00000 (the “LICENSEE”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the License Agreement.
WHEREAS, LICENSOR and LICENSEE executed the License Agreement having an effective date of October 6, 2015, the First Amendment to the License Agreement dated September 16, 2016, the Second Amendment to the License Agreement dated October 30, 2016, and the Third Amendment to the License Agreement (the “Third Amendment”) dated April 26, 2022 (the “Third Amendment Effective Date”);
WHEREAS, the completion of a firmly underwritten initial public offering and sale of shares of common stock of LICENSEE pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “IPO”), was a condition precedent to the validity and enforceability of the Third Amendment, and the failure to complete the IPO within twelve months from the Third Amendment Effective Date rendered the Third Amendment null and void ab initio;
WHEREAS, LICENSOR desires the LICENSEE to have an IPO and is willing to amend the License Agreement;
NOW, THEREFORE, in consideration of the mutual covenants and agreement of terms set forth herein, and for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
1. | LICENSEE AGREEMENT – ARTICLE IV–ROYALTIES, PAYMENTS AND REPORTS |
Replace Section B.2. of Article IV – Royalties, Payments and Reports with the following:
Upon written notification to LICENSOR, LICENSEE may incorporate the New Inventions into the Patent Rights. For New Inventions that are: (a) solely owned or controlled by LICENSOR, LICENSOR’s equity ownership interest shall increase by 25,000 shares of LICENSEE’s common stock for each New Invention having the same Docket # (e.g. from current Patent Rights, all cases bearing the docket number “10613-023” belong to the same patent family, while all cases bearing the docket number “10613-026” belong to a different patent family) that is/are incorporated into the Patent Rights and added to Appendix A Patent Rights, or (b) Joint Inventions or Jointly Owned Patent Rights, LICENSOR’s equity ownership interest shall increase by 6,250 shares of LICENSEE’s common stock for each New Inventions having the same Docket # that is/are incorporated into the Patent Rights and added to Appendix A Joint Owned Patent Rights. The shares of LICENSEE’s common stock to be issued pursuant to this Section B.2 shall be appropriately adjusted in the event of any stock dividend, stock split, revenue stock split or other similar recapitalization with respect to the shares of common stock of the LICENSEE.
2. | LICENSOR hereby waives its rights under Article IV Section H of the License Agreement with regard to LICENSOR’s right to sell all or a portion of LICENSOR’s stake in LICENSEE at the time of an IPO. In addition, LICENSOR agrees to enter into a commercially reasonable lock-up agreement with LICENSEE’s underwriter that will prohibit LICENSOR from transferring or selling any of LICENSEE’s common stock at the IPO and for the six months immediately following the IPO. |
3. | LICENSOR and LICENSEE acknowledge that the list of Licensed Patents (as defined in the License Agreement) attached hereto as Exhibit A is a complete, true, and accurate list of the Licensed Patents that have been licensed in accordance with and are subject to the terms and conditions of the License Agreement. |
4. | Completion of the IPO is a condition precedent to the validity and enforceability of this Fourth Amendment and failure to complete the IPO within twelve (12) months from the Fourth Amendment Effective Date will render this Fourth Amendment null and void ab initio. |
5. | Except as expressly provided in this Fourth Amendment, all other terms, conditions and provisions of the License Agreement and prior Amendments shall continue in full force and effect as provided therein. |
[Signatures on following page]
Page 1 of 18 |
IN WITNESS WHEREOF, the parties hereto have caused these presents to be signed by their respective duly authorized officers.
UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. | HESPEROS, INC. | |||
Signature: | /s/ Xx. Xxxxxxxx Xxxxxx | Signature: | /s/ Xxxxxxx X. Xxxxxx | |
Name: | Xx. Xxxxxxxx Xxxxxx | Name: | Xxxxxxx X. Xxxxxx | |
Title: | Vice President for Technology Transfer | Title: | President | |
Date: | Date: |
Page 2 of 18 |
EXHIBIT A
PATENT RIGHTS
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
31474 |
10613-011PV1 |
61/159,851 |
3/13/2009 |
Quantitative stress measurements in bio- microelectromechanical system for testing activity of potential treatments on mammalian skeletal muscle |
Xxxxx Xxxxxxx |
Expired | ||||||||||
31644 |
10613-011PV2 |
61/259,715 |
11/10/2009 |
Apparatus for measurement of muscle fiber contractile force and associated methods |
Xxxxx Xxxxxxx, Xxxxx Xxxxxx |
Expired | ||||||||||
31794 |
10613-011US1 |
12/661,323 |
3/15/2010 |
Bio- microelectromechanical system transducer and associated methods |
Xxxxx Xxxxxxx |
Abandoned | ||||||||||
33404 |
10613-011US2 |
15/594,697 |
5/15/2017 |
10,386,360 |
8/20/2019 |
Bio- microelectromechanical system transducer and associated methods |
Xxxxx Xxxxxxx |
Issued |
Page 3 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
31541 | 10613-012PV1 | 61/171,958 | 4/23/2009 |
Tissue engineering the neuromuscular junction: A defined model system | Xxxxx Xxxxxxx | Expired | ||||||||||
31821 | 10613-012US1 | 12/765,996 | 4/23/2010 |
8,815,584 |
8/26/2014 |
Method of co-culturing mammalian muscle cells and motoneurons | Xxxxx Xxxxxxx, Xxxxxx Xxx | Issued | ||||||||
33024 |
10613-012US2 |
14/299,802 |
6/9/2014 |
9,650,606 |
5/16/2017 |
Method of co-culturing mammalian muscle cells and motoneurons | Xxxxx Xxxxxxx, Xxxxxx Xxx | Issued | ||||||||
33675 | 10613-012US3 | 15/594,895 | 5/15/2017 |
10,266,804 |
4/23/2019 |
Method of co-culturing mammalian muscle cells and motoneurons | Xxxxx Xxxxxxx, Xxxxxx Xxx | Issued | ||||||||
31838 | 10613-013PV1 | 61/331,999 | 5/6/2010 |
Neuromuscular junction formation between human stem cell-derived motoneurons and rat skeletal muscle in a defined system | Xxxxx Xxxxxxx, Xxxxxxx Xxx, Xxxxx Xxxxxxxxx, Xxxxxxxx Xxxxxxxx | Expired | ||||||||||
32132 | 10613-013US1 | 13/102,672 | 5/6/2011 |
9,952,204 |
4/24/2018 |
Formation of neuromuscular junctions in a defined system | Xxxxx Xxxxxxx, Xxxxxxx Xxx, Xxxxx Xxxxxxxxx, Xxxxxxxx Xxxxxxxx | Issued |
Page 4 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
31839 | 10613-014PV1 | 61/332,003 | 5/6/2010 |
Neuromuscular junction formation between human stem cell-derived motoneurons and human skeletal muscle in a defined system | Xxxxx Xxxxxxx, Xxxxxxx Xxx | Expired | ||||||||||
32144 |
10613-014WO1 |
PCT/US11/35585 |
5/6/2011 |
Formation of neuromuscular junctions in a defined system | Xxxxx Xxxxxxx, Xxxxxxx Xxx | Expired
| ||||||||||
32605 |
10613-014CA1 |
2,798,777 |
11/6/2012 |
2,798,777 |
9/06/2016 |
Formation of neuromuscular junctions in a defined system | Xxxxx Xxxxxxx, Xxxxxxx Xxx | Issued | ||||||||
32606 |
10613-014EP1 |
11772857.6 |
11/19/2012 |
2585171 |
12/26/2018 |
Formation of neuromuscular junctions in a defined system | Xxxxx Xxxxxxx, Xxxxxxx Xxx | Issued | ||||||||
33971 |
10613-014CH1 |
11772857.6 |
12/26/2018 |
2585171 |
12/26/2018 |
Formation of neuromuscular junctions in a defined system | Xxxxx Xxxxxxx, Xxxxxxx Xxx | Issued |
Page 5 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
33972 |
10613-014DE1 |
11772857.6 |
12/26/2018 |
602011055172.8 |
12/26/2018 |
Formation of neuromuscular junctions in a defined system | Xxxxx Xxxxxxx, Xxxxxxx Xxx | Issued | ||||||||
33973 |
10613-014BE1 |
11772857.6 |
12/26/2018 |
2585171 |
12/26/2018 |
Formation of neuromuscular junctions in a defined system | Xxxxx Xxxxxxx, Xxxxxxx Xxx | Issued | ||||||||
33970 |
10613-014FR1 |
11772857.6 |
12/26/2018 |
2585171 |
12/26/2018 |
Formation of neuromuscular junctions in a defined system | Xxxxx Xxxxxxx, Xxxxxxx Xxx | Issued | ||||||||
33974 |
10613-014NL1 |
11772857.6 |
12/26/2018 |
2585171 |
12/26/2018 |
Formation of neuromuscular junctions in a defined system | Xxxxx Xxxxxxx, Xxxxxxx Xxx | Issued | ||||||||
33969 |
10613-014UK1 |
11772857.6 |
12/26/2018 |
2585171 |
12/26/2018 |
Formation of neuromuscular junctions in a defined system | Xxxxx Xxxxxxx, Xxxxxxx Xxx | Issued | ||||||||
32604 | 10613-014US1 | 13/696,396 | 11/6/2012 |
8,835,168 |
9/16/2014 |
Synthetic mammalian neuromuscular junction and method of making | Xxxxx Xxxxxxx, Xxxxxxx Xxx | Issued |
Page 6 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
33052 | 10613-014US2 | 14/453,207 | 8/6/2014 |
9,267,936 |
2/23/2016 | Synthetic mammalian neuromuscular junction and method of screening for a candidate drug xxxxxxx | Xxxxx Xxxxxxx, Xxxxxxx Xxx | Issued | ||||||||
31542 | 10613-015PV1 | 61/171,968 | 4/23/2009 |
Model for skeletal muscle tissue engineering | Xxxxx Xxxxxxx | Expired | ||||||||||
31820 |
10613-015US1 |
12/765,399 |
4/22/2010 |
9,163,216 |
10/20/2015 |
Method for culturing skeletal muscle for tissue engineering | Xxxxx Xxxxxxx, Xxxxxx Xxx, Xxxx Xxxxxx | Issued | ||||||||
33369 |
10613-015US2 |
14/886,577 |
10/19/2015 |
10,160,953 |
12/25/2018 |
Improved method for culturing skeletal muscle for tissue engineering | Xxxxx Xxxxxxx, Xxxxxx Xxx, Xxxx Xxxxxx | Issued | ||||||||
31540 | 10613-017PV1 | 61/181,737 | 5/28/2009 |
Node of ranvier formation on motoneurons in vitro | Xxxxx Xxxxxxx, Xxxx Xxxxxx | Expired | ||||||||||
31869 | 10613-017US1 | 12/788,732 | 5/27/2010 |
8,828,721 |
9/9/2014 |
Method of myelinating isolated motoneurons | Xxxxx Xxxxxxx, Xxxx Xxxxxx | Issued | ||||||||
31608 | 10613-019PV1 | 61/252,195 | 10/16/2009 |
In vitro method of screening new drugs for cardiac toxicity | Xxxxx Xxxxxxx, Xxxxx Xxxxxx, Xxxxxxx Xxxxxxxxx | Expired |
Page 7 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
31640 | 10613-019PV2 | 61/257,504 | 11/3/2009 |
Method of screening new drugs for cardiac toxicity | Xxxxx Xxxxxxx, Xxxxx Xxxxxx, Xxxxxxx Xxxxxxxxx, Xxxxx Xxxxxxxxx | Expired | ||||||||||
32016 |
10613-019US1 |
12/938,701 |
11/3/2010 |
9,404,140 |
8/2/2016 |
Patterned cardiomyocyte culture on microelectrode array | Xxxxx Xxxxxxx, Xxxxx Xxxxxx, Xxxxxxx Xxxxxxxxx, Xxxxx Xxxxxxxxx | Issued | ||||||||
33468 | 10613-019US2 | 15/190,958 | 6/23/2016 |
Patterned cardiomyocyte culture on microelectrode array | Xxxxx Xxxxxxx, Xxxxx Xxxxxx, Xxxxxxx Xxxxxxxxx, Xxxxx Xxxxxxxxx | Abandoned | ||||||||||
32236 |
10613-023PV1 |
61/684,168 |
8/17/2012 |
Methods, systems and compositions for in vitro cellular models of mammalian systems | Xxxxx Xxxxxxx | Expired |
Page 8 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
32726 |
10613-023PV2 |
61/789,184 |
3/15/2013 |
Methods, systems and compositions for in vitro cellular models of mammalian systems | Xxxxx Xxxxxxx | Expired | ||||||||||
32808 |
10613-023WO1 |
PCT/US13/55433 |
8/16/2013 |
Methods, systems and compositions for in vitro cellular models of mammalian systems | Xxxxx Xxxxxxx |
Expired | ||||||||||
32829 | 10613-023WO2 | PCT/US13/55617 | 8/19/2013 |
Methods, systems and compositions for in vitro cellular models of mammalian systems | Xxxxx Xxxxxxx | Expired | ||||||||||
33218 |
10613-023EP1 |
13829508.4 |
3/17/2015 |
Methods, systems and compositions for in vitro cellular models of mammalian systems | Xxxxx Xxxxxxx | Abandoned | ||||||||||
33219 |
10613-023JP1 |
2015-527683 |
2/16/2015 |
Methods, systems and compositions for in vitro cellular models of mammalian systems | Xxxxx Xxxxxxx | Abandoned |
Page 9 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
33217 |
10613-023US1 |
14/422,082 |
2/17/2015 |
Methods, systems and compositions for in vitro cellular models of mammalian systems | Xxxxx Xxxxxxx | Abandoned | ||||||||||
34566 |
10613-023US2 |
16/985,744 |
8/5/2020 |
Methods, systems and compositions for in vitro cellular models of mammalian systems | Xxxxx Xxxxxxx | Pending | ||||||||||
32624 | 10613-025PV1 | 61/732,042 | 11/30/2012 |
Derivation of sensory neurons and neural crest stem cells from human neural progenitor hNP1 | Xxxxx Xxxxxxx, Xxxxxxx Xxx, Xxxxxx Xxxxxxxxx | Expired | ||||||||||
32625 | 10613-025PV2 | 61/732,574 | 12/3/2012 |
Derivation of sensory neurons and neural crest stem cells from human neural progenitor hNP1 | Xxxxx Xxxxxxx, Xxxxxxx Xxx, Xxxxxx Xxxxxxxxx | Expired | ||||||||||
32717 | 10613-025PV3 | 61/784,923 | 3/14/2013 |
Compositions and methods for generating neural crest stem cells | Xxxxx Xxxxxxx, Xxxxxxx Xxx, Xxxxxx Xxxxxxxxx | Expired | ||||||||||
32868 | 10613-025WO1 | PCT/US13/72382 | 11/27/2013 |
Derivation of sensory neurons and neural crest stem cells from human neural progenitor hNP1 | Xxxxx Xxxxxxx, Xxxxxxx Xxx, Xxxxxx Xxxxxxxxx | Expired |
Page 10 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
33265 | 10613-025US1 | 14/648,190 | 5/28/2015 |
Compositions and methods for generating neural crest stem cells and sensory neurons | Xxxxx Xxxxxxx, Xxxxxxx Xxx, Xxxxxx Xxxxxxxxx | Xxxxxxxxx | ||||||||||
32665 | 10613-026PV1 | 61/758,628 | 1/30/2013 |
Compositions and methods comprising cardiac myocytes | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx |
Expired | ||||||||||
32723 | 10613-026PV2 | 61/790,061 | 3/15/2013 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx |
Expired |
Page 11 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
32927 | 10613-026WO1 | PCT/US14/13903 | 1/30/2014 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx |
Expired | ||||||||||
33306 |
10613-026CA1 |
2,899,445 |
7/27/2015 |
2,899,445 |
4/4/2023 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx |
Issued | ||||||||
33307 | 10613-026EP1 | 14745661.0 | 8/28/2015 |
2951281 |
6/27/2018 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx |
Issued |
Page 12 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
33880 |
10613-026BE1 |
14745661.0 |
6/27/2018 |
2951281 |
6/27/2018 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx
|
Issued | ||||||||
33879 |
10613-026CH1 |
14745661.0 |
6/27/2018 |
2951281 |
6/27/2018 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx
|
Issued | ||||||||
33878 |
10613-026DE1 |
14745661.0 |
6/27/2018 |
602014027552.4 |
6/27/2018 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx
|
Issued |
Page 13 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
33877 |
10613-026FR1 |
14745661.0 |
6/27/2018 |
2951281 |
6/27/2018 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx
|
Issued | ||||||||
33411 | 10613-026HK1 | 15112635.9 | 12/23/2015 |
XX0000000 |
9/20/2019 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx |
Issued | ||||||||
33881 |
10613-026NL1 |
14745661.0 |
6/27/2018 |
2951281 |
6/27/2018 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx
|
Issued |
Page 14 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
33876 | 10613-026UK1 | 14745661.0 |
6/27/2018 |
2951281 |
6/27/2018 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx |
Issued | ||||||||
33305 | 10613-026US1 | 14/764,683 |
7/30/2015 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx |
Abandoned |
Page 15 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
34458 | 10613-026US2 | 16/913,528 |
6/26/2020 |
11,614,437 |
3/28/2023 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx |
Issued | ||||||||
10609-15 | 10613-026US3 | 18/125,879 |
3/24/2023 |
Devices and systems for mimicking heart function | Xxxxx Xxxxxxx; Xxxxxxxxxxx Xxxx; Xxxxxxxxxxx XxXxxxx; Xxxxx Xxxxxx; Xxxxx Xxxxxxxxx |
Xxxxxxx |
Page 16 of 18 |
UCF ID No. | Docket # | Application No. | Filing Date | Patent No. | Issue Date | Title | Inventors | Status | ||||||||
32794 |
10613-029PV1 |
62/034,217 |
8/7/2014 |
Devices and methods comprising neuromuscular junctions | Xxxxx Xxxxxxx |
Expired | ||||||||||
33288 |
10613-029US1 |
14/821,675 |
8/7/2015 |
10,935,541 |
3/2/2021 |
Devices and methods comprising neuromuscular junctions | Xxxxx Xxxxxxx, Xxxxxxxxxxx Xxxx, Xxxxxxx Xxxxxxx, Xxxxxxxxx Xxxxx |
Issued | ||||||||
33390 |
10613-045PV1 |
62/379,892 |
8/26/2016 |
Multi-Component In Vitro System To Deduce Cell Signaling Pathways By Electronic Stimulation Patterns | Xxxxx Xxxxxxx, Xxx Xxxxxxxxx, Xxxxxxxxxx Xxxxxxxxx |
Expired | ||||||||||
33731 |
10613-045WO1 |
PCT/US2017/047085 |
8/16/2017 |
Multi-Component In Vitro System To Deduce Cell Signaling Pathways By Electronic Stimulation Patterns | Xxxxx Xxxxxxx, Xxx Xxxxxxxxx, Xxxxxxxxxx Xxxxxxxxx |
Expired | ||||||||||
34040 |
10613-045US1 |
16/328,417 |
2/26/2019 |
11,022,605 |
6/1/2021 |
Multi-Component In Vitro System To Deduce Cell Signaling Pathways By Electronic Stimulation Patterns | Xxxxx Xxxxxxx, Xxx Xxxxxxxxx, Xxxxxxxxxx Xxxxxxxxx |
Issued |
Page 17 of 18 |
APPENDIX A
JOINTLY OWNED PATENT RIGHTS
UCF ID # | Docket # | Serial # | Title | Inventors | Filing/Issue Date | Status | Joint Owner | |||||||
33554 |
10613-052PV1 |
62/440,968 |
Pumpless microfluidic organ-on-a-chip system including a functional immune system | Xxxxx Xxxxxxx, Xxxxxx Xxxxx, Xxxxxx Xxxxxxxx, Xxxxxxxxxxx XxXxxxx, Xxxx Xxxxxx, Xxxxxx Xxxxxxxxx | 12/30/2016 |
Expired |
Licensee | |||||||
33796 |
10613-052WO1 |
PCT/US2017/068952 |
Pumpless microfluidic organ-on-a-chip system including a functional immune system | Xxxxx Xxxxxxx, Xxxxxx Xxxxx, Xxxxxx Xxxxxxxx, Xxxxxxxxxxx XxXxxxx, Xxxx Xxxxxx, Xxxxxx Xxxxxxxxx | 12/29/2017 |
Expired |
Licensee | |||||||
34194 |
10613-052CA1 |
3,048,884 |
Pumpless microfluidic organ-on-a-chip system including a functional immune system | Xxxxx Xxxxxxx, Xxxxxx Xxxxx, Xxxxxx Xxxxxxxx, Xxxxxxxxxxx XxXxxxx, Xxxx Xxxxxx, Xxxxxx Xxxxxxxxx | 6/27/2019 |
Pending |
Licensee | |||||||
34198 |
10613-052EP1 |
17885858.5 |
Pumpless microfluidic organ-on-a-chip system including a functional immune system | Xxxxx Xxxxxxx, Xxxxxx Xxxxx, Xxxxxx Xxxxxxxx, Xxxxxxxxxxx XxXxxxx, Xxxx Xxxxxx, Xxxxxx Xxxxxxxxx | 7/22/2019 |
Pending |
Licensee | |||||||
34431 |
10613-052HK1 |
62020006877.8 |
Pumpless microfluidic organ-on-a-chip system including a functional immune system | Xxxxx Xxxxxxx, Xxxxxx Xxxxx, Xxxxxx Xxxxxxxx, Xxxxxxxxxxx XxXxxxx, Xxxx Xxxxxx, Xxxxxx Xxxxxxxxx | 5/4/2020 |
Pending |
Licensee | |||||||
34193 |
10613-052US1 |
16/474,768 |
Pumpless microfluidic organ-on-a-chip system including a functional immune system | Xxxxx Xxxxxxx, Xxxxxx Xxxxx, Xxxxxx Xxxxxxxx, Xxxxxxxxxxx XxXxxxx, Xxxx Xxxxxx, Xxxxxx Xxxxxxxxx | 1/17/2023 | Issued |
Licensee |
Page 18 of 18 |